Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.


Science 23 December 1977:
Vol. 198. no. 4323, pp. 1274 - 1276
DOI: 10.1126/science.337493

Articles

Science, Vol 198, Issue 4323, 1274-1276
Copyright © 1977 by American Association for the Advancement of Science


articles

Methylphenidate in hyperkinetic children: differences in dose effects on learning and social behavior

RL Sprague and EK Sleator

Methylphenidate (Ritalin) is widely prescribed for hyperkinetic children. This study showed a peak enchancement of learning in children after being given a dose of 0.3 milligram per kilogram of body weight, and a decrement in learning in those given larger doses; social behavior showed the most improvement in children given 1.0 milligram per kilogram. These results had been hypothesized from theoretical dose-response curves which indicate different target behaviors would improve at different doses.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Practice Parameter for the Use of Stimulant Medications in the Treatment of Children, Adolescents, and Adults.
L. L. Greenhill, S. Pliszka, M. K. Dulcan, W. Bernet, V. Arnold, J. Beitchman, R. S. Benson, O. Bukstein, J. Kinlan, J. McClellan, et al. (2004)
Focus 2, 642-668
   Abstract »    Full Text »    PDF »
2001 American Academy of Pediatrics Practice Parameter on Attention-Deficit/Hyperactivity Disorder.
A. S. Yusin, J. M. Perrin, M. Wolraich, and M. Stein (2004)
Pediatrics 113, 428-429
   Full Text »    PDF »
A Dose-Response Study of OROS Methylphenidate in Children With Attention-Deficit/Hyperactivity Disorder.
M. A. Stein, C. S. Sarampote, I. D. Waldman, A. S. Robb, C. Conlon, P. L. Pearl, D. O. Black, K. E. Seymour, and J. H. Newcorn (2003)
Pediatrics 112, e404-404
   Abstract »    Full Text »    PDF »
Catechol O-methyltransferase val158-met genotype and individual variation in the brain response to amphetamine.
V. S. Mattay, T. E. Goldberg, F. Fera, A. R. Hariri, A. Tessitore, M. F. Egan, B. Kolachana, J. H. Callicott, and D. R. Weinberger (2003)
PNAS 100, 6186-6191
   Abstract »    Full Text »    PDF »
Efficacy of Methylphenidate in Patients With Cerebral Palsy and Attention-Deficit Hyperactivity Disorder (ADHD).
V. Gross-Tsur, R. S. Shalev, N. Badihi, and O. Manor (2002)
J Child Neurol 17, 863-866
   Abstract »    PDF »
Comparison between Intraperitoneal and Oral Methylphenidate Administration: A Microdialysis and Locomotor Activity Study.
M. R. Gerasimov, M. Franceschi, N. D. Volkow, A. Gifford, S. J. Gatley, D. Marsteller, P. E. Molina, and S. L. Dewey (2000)
J. Pharmacol. Exp. Ther. 295, 51-57
   Abstract »    Full Text »
Reviews : Pharmacotherapy of adolescent attention deficit hyperactivity disorder: challenges, choices and caveats.
E. J. Garland (1998)
J Psychopharmacol 12, 385-395
   Abstract »    PDF »
Medication for Children With Attention Disorders.
I. J. Kash;, E. R. Colson;, J. M. Perrin, G. Erenberg, and F. Member (1997)
Pediatrics 99, 922
   Full Text »    PDF »
A clinical protocol for determining methylphenidate dosage levels in ADHD.
J.B. Hoeppner, J.B. Hale, A.M. Bradley, M. Byrnes, D.L. Coury, L. Lennie, and B.L. Trommer (1997)
J Atten Disord 2, 19-30
   Abstract »
Attempting to Make Clinical Science More Scientific.
L. E. Arnold (1997)
J Atten Disord 2, 33-34
Hemispheric Processing and Methylphenidate Effects in Attention-Deficit Hyperactivity Disorder.
M. A. Malone, J. R. Kershner, and J. M. Swanson (1994)
J Child Neurol 9, 181-189
   Abstract »    PDF »
Classroom Behavior and Family Climate in Students with Learning Disabilities and Hyperactive Behavior.
M. Margalit and K. Almougy (1991)
J Learn Disabil 24, 406-412
   Abstract »    PDF »
Stimulant Medication and Parent Training Therapies for Attention Deficit-Hyperactivity Disorder.
A. D. Anastopoulos, G. J. DuPaul, and R. A. Barkley (1991)
J Learn Disabil 24, 210-218
   Abstract »    PDF »
Effects of Stimulant Medication on Learning in Children with ADHD.
J. M. Swanson, D. Cantwell, M. Lerner, K. McBurnett, and G. Hanna (1991)
J Learn Disabil 24, 219-230
   Abstract »    PDF »
Stimulant Medication and Attention Deficit--Hyperactivity Disorder: The Child's Perspective.
J. Bowen, T. Fenton, and L. Rappaport (1991)
Arch Pediatr Adolesc Med 145, 291-295
   Abstract »    PDF »
Clinical Management of Attention Deficit Hyperactivity Disorder.
K. K.S. Voeller (1991)
J Child Neurol 6, S51-S67
   Abstract »    PDF »
ADHD: Facts and Fallacies.
R. E. Reeve (1990)
Intervention in School and Clinic 26, 70-78
   Abstract »    PDF »
Effects of Theophylline on Behavior and Learning in Children With Asthma.
L. Rappaport, H. Coffman, R. Guare, T. Fenton, C. DeGraw, and F. Twarog (1989)
Arch Pediatr Adolesc Med 143, 368-372
   Abstract »    PDF »
Academic Competence and Social Adjustment of Boys with Learning Disabilities and Boys with Behavior Disorders.
M. Margalit (1989)
J Learn Disabil 22, 41-45
   PDF »
A Controlled Trial of Methylphenidate in Black Adolescents: Attentional, Behavioral, and Physiological Effects.
R. T. Brown and S. B. Sexson (1988)
Clinical Pediatrics 27, 74-81
   Abstract »    PDF »
The Future of the Field: Intervention Approaches.
C. R. Smith (1986)
J Learn Disabil 19, 461-472
   Abstract »    PDF »
Hyperactivity and Learning Difficulties.
P. L. Holborow and P. S. Berry (1986)
J Learn Disabil 19, 426-431
   Abstract »    PDF »
Teacher Ratings and the Assessment of Attention Deficit Disordered Children.
R. T. Brown (1986)
J Learn Disabil 19, 95-100
   Abstract »    PDF »
Methylphenidate and Children With Attention Deficit Disorder: Dose Effects on Classroom Academic and Social Behavior.
W. E. Pelham, M. E. Bender, J. Caddell, S. Booth, and S. H. Moorer (1985)
Arch Gen Psychiatry 42, 948-952
   Abstract »    PDF »
Effects of Stimulant Drugs on Academic Performance in Hyperactive and Learning Disabled Children.
K. D. Gadow (1983)
J Learn Disabil 16, 290-299
   Abstract »    PDF »
Effects of Thioridazine on the Intellectual Performance of Mentally Retarded Drug Responders and Nonresponders.
S. E. Breuning, D. G. Ferguson, N. A. Davidson, and A. D. Poling (1983)
Arch Gen Psychiatry 40, 309-313
   Abstract »    PDF »
Hyperkinesis : Myth, Mystery, and Matter.
R. W. Schworm (1982)
Journal of Special Education 16, 129-148
   Abstract »    PDF »
Case Studies of Effects of Artificial Food Colors On Hyperactivity.
C. Spring, J. Vermeersch, D. Blunden, and H. Sterling (1981)
Journal of Special Education 15, 361-372
   Abstract »    PDF »
Cultural Differences in the Hyperactive Syndrome Rated in the Conners Abbreviated Scale.
M. Margalit (1981)
J Learn Disabil 14, 330-331
   Abstract »    PDF »
Food Dyes and Impairment of Performance in Hyperactive Children.
J. M. SWANSON and M. KINSBOURNE (1981)
Science 211, 411
   PDF »
Communication Performance Changes as a Function of Ritalin Dosage: A Case Study.
C. Highnam (1981)
Communication Disorders Quarterly 5, 126-135
   Abstract »    PDF »
Multimodality Treatment: A Two-Year Evaluation of 61 Hyperactive Boys.
J. H. Satterfield, B. T. Satterfield, and D. P. Cantwell (1980)
Arch Gen Psychiatry 37, 915-919
   Abstract »    PDF »
Food dyes impair performance of hyperactive children on a laboratory learning test.
J. Swanson and M Kinsbourne (1980)
Science 207, 1485-1487
   Abstract »    PDF »
Psychotropic Drugs and Learning Problems--A Selective Review.
M. G. Aman (1980)
J Learn Disabil 13, 87-97
   Abstract »    PDF »
Erythrosine (Red No. 3) and its nonspecific biochemical actions: what relation to behavioral changes?.
R. Mailman, R. Ferris, F. Tang, R. Vogel, C. Kilts, M. Lipton, D. Smith, R. Mueller, and G. Breese (1980)
Science 207, 535-537
   Abstract »    PDF »
Hyperactivity and Medication-Reply.
J. R. VARGA (1979)
Arch Pediatr Adolesc Med 133, 1288
   Abstract »    PDF »
Hyperactivity and Medication.
R. D. SMITH (1979)
Arch Pediatr Adolesc Med 133, 1287-1288
   Abstract »    PDF »
The hyperactive child syndrome.
G Weiss and L Hechtman (1979)
Science 205, 1348-1354
   Abstract »    PDF »
Methylphenidate vs Dextroamphetamine vs Caffeine in Minimal Brain Dysfunction: Controlled Comparison by Placebo Washout Design With Bayes' Analysis.
L. E. Arnold, J. Christopher, R. Huestis, and D. J. Smeltzer (1978)
Arch Gen Psychiatry 35, 463-473
   Abstract »    PDF »



To Advertise     Find Products


Science. ISSN 0036-8075 (print), 1095-9203 (online)